About Careers MedBlog Contact us

New Test Based on Tumor-Specific MRNA Helps Early Detection of Ovarian Cancer

by Vishnuprasad on May 26, 2015 at 6:53 PM
Font : A-A+

New Test Based on Tumor-Specific MRNA Helps Early Detection of Ovarian Cancer

Opening up the possibility for early diagnosis of ovarian cancer, scientists have identified genetic material that distinguishes its cells from normal cells.

The genetic material contains six mRNA isoforms produced by ovarian cancer cells but not normal cells could be used to diagnose early-stage ovarian cancer.


Ovarian cancer is very difficult to diagnose and treat, making it an especially fatal disease.

"We were inspired by many studies aimed at using DNA to detect cancer," said first author Christian Barrett at University of California, San Diego School of Medicine and Moores Cancer Center. "But we wondered if we could instead develop an ovarian cancer detection test based on tumor-specific mRNA that has disseminated from cancer cells to the cervix and can be collected during a routine Pap test," Barrett said.

They identified six mRNA isoform molecules that have the tumor specificity required for an early detection diagnostic of ovarian cancer. In contrast to DNA, mRNAs are complementary copies of the genes and carry the recipe for every protein that the cell will produce from the nucleus to the cytoplasm.

Whereas a cancer cell might harbor just one or a few copies of a DNA mutation, but mRNA variants can occur in hundreds to thousands of copies per cell.

For the study, the team analyzed mRNA sequence data from 296 ovarian cancers and 1,839 normal tissue samples.

"Our experimental findings were made in a laboratory and were performed on ovarian cancer cells from cell lines," said study co-author Cheryl Saenz, a clinical professor of reproductive medicine at University of California.

The study was outlined in the Proceedings of the National Academy of Sciences.

Source: Medindia


Recommended Reading

Latest Cancer News

 Tobacco Use Among Cancer Patients Likely to Increase Symptom Burden
A new study assessed the association of cigarette smoking and vaping on cancer-related symptom burden (fatigue, pain, emotional problems) and quality of life.
Breaking New Ground in Breast Cancer Therapy Without Chemotherapy
Scientists are making strides in personalized breast cancer therapy by developing a highly accurate molecular classifier test for breast cancer patients.
 Prostate Cancer 'Test by Request' Policies: Beneficial or Detrimental
Experts suggest high-income countries implement a comprehensive risk-based approach for prostate-specific antigen (PSA) testing to reduce overdiagnosis and overtreatment.
 Oral Cancer Cells Use Fat as Fuel to Escape from Immunity
New study identifies the role of metabolic comorbidities such as obesity in contributing to the immunogenicity of oral cancer through the immune pathway STING-IFN-I.
 Treating Anal Cancer With Smarter and Kinder Approach
Recent clinical trial results have shown that reducing the dose and duration of radiotherapy treatments for anal cancer may result in fewer side effects.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

New Test Based on Tumor-Specific MRNA Helps Early Detection of Ovarian Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests